Proteolytically-cleaved fragments of cell surface proteins stimulate a cytotoxic immune response against tumoractivated endothelial cells in vitro

Journal of Cancer Science and Therapy

Volumn 2, Issue 5, 2010, Pages 126-131

  Balashova, Elena E ^a,c   Lokhov, Petr G ^b,c  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c ZAO BioBohemia   (Russian Federation)

Author keywords

Antiangiogenic cancer vaccine; Endothelial cells; Tumor associated antigens

Indexed keywords

CANCER VACCINE; TRYPSIN; TUMOR ANTIGEN;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; PROTEIN DEGRADATION; TUMOR CELL; VACCINE PRODUCTION;

EID: 77957953395     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000037     Document Type: Article

References (51)

1. Arap W, Pasqualini R, Ruoslahti E (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279: 377-380.
2. Bhati R, Patterson C, Livasy CA, Fan C, Ketelsen D, et al. (2008) Molecular characterization of human breast tumor vascular cells. Am J Pathol 172: 1381-1390.
3. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
4. Chen XY, Zhang W, Wu S, Bi F, Su YJ, et al. (2006) Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity. Clin Cancer Res 12: 5834-5840.
5. Chiang CL, Benencia F, Coukos G (2010) Whole tumor antigen vaccines. Semin Immunol 22: 132-143.
6. Cohen EP, Chopra A, O-Sullivan I, Kim TS (2009) Enhancing cellular cancer vaccines. Immunotherapy 1: 495-50.
7. Copier J, Dalgleish A (2010) Whole-cell vaccines: A failure or a success waiting to happen? Curr Opin Mol Ther 12: 14-20.
8. Corsini E, Gelati M, Calatozzolo C, Alessandri G, Frigerio S, et al. (2004) Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization. Cancer Immunol Immunother 53: 955-962.
9. de Gruijl TD, van den Eertwegh AJ, Pinedo HM, Scheper RJ (2008) Wholecell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines. Cancer Immunol Immunother 57: 1569-1577.
10. Deblaquiere J, Burgess A (1999) Affi nity purifi cation of plasma membranes. J Biomol Tech 10: 64-71.
11. Ellis LM, Fidler IJ (1996) Angiogenesis and metastasis. Eur J Cancer 32: 2451-2460.
12. Emens LA (2006) Roadmap to a better therapeutic tumor vaccine. Int Rev Immunol 25: 415-443.
13. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
14. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6.
15. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286.
16. Folkman J, Haudenschild C (1980) Angiogenesis in vitro. Nature 288: 551-556.
17. Folkman J, Haudenschild CC, Zetter BR (1979) Long-term culture of capillary endothelial cells. Proc Natl Acad Sci U S A 76: 5217-5221.
18. Hewett PW (2001) Identifi cation of tumour-induced changes in endothelial cell surface protein expression: an in vitro model. Int J Biochem Cell Biol 33: 325-335.
19. Hewett PW, Murray JC (1994) Human omental mesothelial cells: A simple method for isolation and discrimination from endothelial cells. In Vitro Cell Dev Biol 30: 145-147.
20. Hewett PW, Murray JC, Price EA, Watts ME, Woodcock M (1993) Isolation and characterization of microvessel endothelial cells from human mammary adipose tissue. In Vitro Cell Dev Biol Anim 29A: 325-331.
21. Hudson L, Hay FC (1980) Practical Immunology. Blackwell Scientific Publications, Oxford, 29-31.
22. Hull MA, Hewett PW, Brough JL, Hawkey CJ (1996) Isolation and culture of human gastric endothelial cells. Gastroenterology 111: 1230-1240.
23. Hutley LJ, Herington AC, Shurety W, Cheung C, Vesey DA, et al. (2001) Human adipose tissue endothelial cells promote preadipocyte proliferation. Am J Physiol Endocrinol Metab 281: E1037-E1044.
24. John J, Dalgleish A, Melcher A, Pandha H (2005) Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination. J Immunol Methods 299: 37-46.
25. Khodarev NN, Yu J, Labay E, Darga T, Brown CK, et al. (2003) Tumourendothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 116: 1013-1022.
26. Kumar S, West DC, Ager A (1987) Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation 36: 57-70.
27. Lang I, Pabst MA, Hiden U, Blaschitz A, Dohr G, et al. (2003) Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. Eur J Cell Biol 82: 163-173.
28. Lee KH, Lawley TJ, Xu YL, Swerlick RA (1992) VCAM-1-, ELAM-1-, and ICAM-1-independent adhesion of melanoma cells to cultured human dermal microvascular endothelial cells. J Invest Dermatol 98: 79-85.
29. Levine MM, Sztein MB (2004) Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol 5: 460-464.
30. Li A, Li H, Zhang J, Jin G, Xiu R (2003) The mitogenic and anti-apoptotic activity of tumor conditioned medium on endothelium. Clin Hemorheol Microcirc 29: 375-382.
31. Liao F, Doody JF, Overholser J, Finnerty B, Bassi R, et al. (2002) Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res 62: 2567-2575.
32. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336.
33. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, et al. (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4: 328-332.
34. Okaji Y, Tsuno NH, Kitayama J, Saito S, Takahashi T, et al. (2004) Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity. Cancer Sci 95: 85-90.
35. Okaji Y, Tsuno NH, Saito S, Yoneyama S, Tanaka M, et al. (2006) Vaccines targeting tumour angiogenesis--a novel strategy for cancer immunotherapy. Eur J Surg Oncol 32: 363-370.
36. Papetti M, Herman IM (2002) Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282: C947-C970.
37. Pluda JM (1997) Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin Oncol 24: 203-218.
38. Potzsch B, Grulich-Henn J, Rossing R, Wille D, Muller-Berghaus G (1990) Identifi cation of endothelial and mesothelial cells in human omental tissue and in omentum-derived cultured cells by specifi c cell markers. Lab Invest 63: 841-852.
39. Pralhad T, Madhusudan S, Rajendrakumar K (2003) Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases. J Pharm Pharmacol 55: 1045-1053.
40. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, et al. (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180: 83-93.
41. Ruoslahti E, Rajotte D (2000) An address system in the vasculature of normal tissues and tumors. Annu Rev Immunol 18: 813-827.
42. Scappaticci FA (2002) Mechanisms and future directions for angiogenesis based cancer therapies. J Clin Oncol 20: 3906-3927.
43. Scappaticci FA, Nolan GP (2003) Induction of anti-tumor immunity in mice using a syngeneic endothelial cell vaccine. Anticancer Res 23: 1165-1172.
44. Schraa AJ, Everts M, Kok RJ, Asgeirsdottir SA, Meijer DK, et al. (2002) Development of vasculature targeting strategies for the treatment of cancer and chronic infl ammatory diseases. Biotechnol Annu Rev 8: 133-165.
45. Shaheen RM, Ahmad SA, Liu W, Reinmuth N, Jung YD, et al. (2001) Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 85: 584-589.
46. Shreeniwas R, Ogawa S, Cozzolino F, Torcia G, Braunstein N, et al. (1991) Macrovascular and microvascular endothelium during long-term hypoxia: alterations in cell growth, monolayer permeability, and cell surface coagulant properties. J Cell Physiol 146: 8-17.
47. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, et al. (2000) Genes expressed in human tumor endothelium. Science 289: 1197-1202.
48. Swerlick RA, Lee KH, Li LJ, Sepp NT, Caughman SW, et al. (1992a) Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 149: 698-705.
49. Swerlick RA, Lee KH, Wick TM, Lawley TJ (1992b) Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 148: 78-83.
50. Thompson PL, Dessureault S (2007) Immune-Mediated Diseases From Theory to Therapy. Springer, New York, 345-355.
51. Wei YQ, Wang QR, Zhao X, Yang L, Tian L, et al. (2000) Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 6: 1160-1166.